Review Article

Release kinetics of 3D printed oral solid dosage forms: An overview

Volume: 1 Number: 2 November 10, 2022
EN

Release kinetics of 3D printed oral solid dosage forms: An overview

Abstract

Three-dimensional printing (3DP) is one of the most extensively researched methods for producing nano/micro scale biomaterials. This method is typically applied layer by layer. The 3DP method has many advantages over traditional manufacturing methods and ensures that personalized drug design is feasible. Individual dose adjustment provides significant benefits, particularly in some disadvantaged patient groups. Individual release characteristics may be required in these patient groups in addition to dose adjustment. 3DP technology also allows for the adjustment of release kinetics. All of these factors were also increasing interest in 3DP technology in the pharmaceutical industry. The goal of this review is to understand the pharmacological significance of 3DP technology as well as the parameters influencing the release profiles in tablets produced by using technique, and to establish a correlation between them. Within the scope of this review, 79 literature research studies were examined, and it was determined that there is limited data to determine whether there is a correlation between release kinetics and 3DP techniques. When the release profiles obtained by considering the polymer type used in these techniques are evaluated, immediate and rapid release was obtained in studies using PVA + PLA polymers and studies using PVP polymer, immediate release in studies using Kollidon® and Kollicoat® derivatives, and controlled, extended and sustained release was observed in studies using PCL polymer.

Keywords

References

  1. 1. Curry EJ, Henoun AD, Miller AN 3rd, Nguyen TD. 3D nano- and micro-patterning of biomaterials for controlled drug delivery. Ther Deliv. 2017;8(1):15-28. https://doi.org/10.4155/tde-2016-0052
  2. 2. Lavan DA, McGuire T, Langer R. Small-scale systems for in vivo drug delivery. Nat Biotechnol. 2003;21(10):1184-1191. https://doi.org/10.1038/nbt876
  3. 3. Prausnitz MR, Mitragotri S, Langer R. Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov. 2004;3(2):115-124. https://doi.org/10.1038/nrd1304
  4. 4. Kaynak MS, Kaş HS, Levent Ö. Formulation of controlled release glipizide pellets using pan coating method. Hacettepe University Journal of the Faculty of Pharmacy. 2007;27(2):93-106.
  5. 5. Langer R. New methods of drug delivery. Science. 1990;249(4976):1527-1533. https://doi.org/10.1126/science.2218494
  6. 6. Liversidge GG, Cundy KC, Bishop JF, Czekai DA, inventors; Particulate Prospects Corp, Elan Corp PLC, Elan Pharma International Ltd, assignee. Surface modified drug nanoparticles. United States patent DC 5,145,684. 1992.
  7. 7. Fang C, Bhattarai N, Sun C, Zhang M. Functionalized nanoparticles with long-term stability in biological media. Small. 2009;5(14):1637-1641. https://doi.org/10.1002/smll.200801647
  8. 8. Kholgh Eshkalak S, Rezvani Ghomi E, Dai Y, Choudhury D, Ramakrishna S. The role of three-dimensional printing in healthcare and medicine. Materials & Design. 2020;194:108940. https://doi.org/10.1016/j.matdes.2020.108940

Details

Primary Language

English

Subjects

Pharmacology and Pharmaceutical Sciences

Journal Section

Review Article

Publication Date

November 10, 2022

Submission Date

September 28, 2022

Acceptance Date

October 21, 2022

Published in Issue

Year 2022 Volume: 1 Number: 2

APA
Kaval, B., Kapkın, E., & Kaynak, M. S. (2022). Release kinetics of 3D printed oral solid dosage forms: An overview. European Journal of Life Sciences, 1(2), 70-88. https://doi.org/10.55971/EJLS.1181158
AMA
1.Kaval B, Kapkın E, Kaynak MS. Release kinetics of 3D printed oral solid dosage forms: An overview. Eur J Life Sci. 2022;1(2):70-88. doi:10.55971/EJLS.1181158
Chicago
Kaval, Berna, Engin Kapkın, and Mustafa Sinan Kaynak. 2022. “Release Kinetics of 3D Printed Oral Solid Dosage Forms: An Overview”. European Journal of Life Sciences 1 (2): 70-88. https://doi.org/10.55971/EJLS.1181158.
EndNote
Kaval B, Kapkın E, Kaynak MS (November 1, 2022) Release kinetics of 3D printed oral solid dosage forms: An overview. European Journal of Life Sciences 1 2 70–88.
IEEE
[1]B. Kaval, E. Kapkın, and M. S. Kaynak, “Release kinetics of 3D printed oral solid dosage forms: An overview”, Eur J Life Sci, vol. 1, no. 2, pp. 70–88, Nov. 2022, doi: 10.55971/EJLS.1181158.
ISNAD
Kaval, Berna - Kapkın, Engin - Kaynak, Mustafa Sinan. “Release Kinetics of 3D Printed Oral Solid Dosage Forms: An Overview”. European Journal of Life Sciences 1/2 (November 1, 2022): 70-88. https://doi.org/10.55971/EJLS.1181158.
JAMA
1.Kaval B, Kapkın E, Kaynak MS. Release kinetics of 3D printed oral solid dosage forms: An overview. Eur J Life Sci. 2022;1:70–88.
MLA
Kaval, Berna, et al. “Release Kinetics of 3D Printed Oral Solid Dosage Forms: An Overview”. European Journal of Life Sciences, vol. 1, no. 2, Nov. 2022, pp. 70-88, doi:10.55971/EJLS.1181158.
Vancouver
1.Berna Kaval, Engin Kapkın, Mustafa Sinan Kaynak. Release kinetics of 3D printed oral solid dosage forms: An overview. Eur J Life Sci. 2022 Nov. 1;1(2):70-88. doi:10.55971/EJLS.1181158

Announcement

Dear Readers, Authors, and Reviewers,

An inconsistency has been identified in the automatically generated editorial board information due to a technical issue in the infrastructure that enables the electronic management of our journal. As a result of this technical problem, the current editorial board information can be accessed on DergiPark at https://dergipark.org.tr/en/pub/ejls/board.

However, the editorial board and reviewer information for a published issue are included in the PDF file of the relevant issue. Therefore, the accurate and authoritative information should be accessed through the PDF of the respective issue.

For your information.

**Click here for an important announcement regarding the Editorial Board.**